TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7519764

Group type: EXPERIMENTAL
Intervention: 12 mg panomifene (PAN)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 120 mg panomifene (PAN)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: FSH and LH (both doses)
Number of subjects: 10
Study: 3191339

Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin
Number of subjects: 60

Group type: COMPARATOR
Intervention: No heparin (control)
Number of subjects: 60
Study: 31691723

Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (500 mg tablet per day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 27825697

Group type: EXPERIMENTAL
Intervention: Infusional 5‐fluorouracil (FU) chemotherapy
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy with irinotecan (IRI)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Doublet chemotherapy (FU + IRI)
Number of subjects: 282
Study: 25313534

Group type: EXPERIMENTAL
Intervention: Paramedian sagittal oblique approach
Number of subjects: 42

Group type: COMPARATOR
Intervention: Paramedian sagittal approach
Number of subjects: 42
Study: 23510513

Group type: EXPERIMENTAL
Intervention: Calcium phosphate (CaP) supplementation (plus 1 g calcium/d)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 10
Study: 21216868

Group type: EXPERIMENTAL
Intervention: ChimeriVax-WN02 vaccine
Number of subjects: 23
Study: 18647268

Group type: EXPERIMENTAL
Intervention: Spicy meal (standard meal mixed with 2 g chili)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Standard meal with 2 g chili in capsules
Number of subjects: 20

Group type: COMPARATOR
Intervention: Spicy meal
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard meal with chili capsules
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard meal
Number of subjects: 20
Study: 17207301

Group type: EXPERIMENTAL
Intervention: PercuTwist
Number of subjects: 130

Group type: COMPARATOR
Intervention: Guide-wire dilating forceps (GWDF)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Percutaneous dilatational tracheostomy (PDT)
Number of subjects: 130
Study: 15508053

Group type: EXPERIMENTAL
Intervention: HFOV
Number of subjects: 52

Group type: COMPARATOR
Intervention: CMV
Number of subjects: 52
Study: 11212591

Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 59

Group type: COMPARATOR
Intervention: Nefazodone
Number of subjects: 59
Study: 9601160

Group type: EXPERIMENTAL
Intervention: Ibuprofen 800 mg/day
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Codeine 120 mg/day
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 8056992

Group type: EXPERIMENTAL
Intervention: Moclobemide (450 mg daily)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Imipramine (150 mg daily)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249
Study: 2658581

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 750 mg or 1,000 mg twice daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin treatment
Number of subjects: 48
Study: 31898191

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise intervention group
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control group (usual lifestyle behaviors)
Number of subjects: 139
Study: 31013131

Group type: EXPERIMENTAL
Intervention: 0.018-inch slot bracket system
Number of subjects: 74

Group type: COMPARATOR
Intervention: 0.022-inch slot bracket system
Number of subjects: 74
Study: 28934438

Group type: EXPERIMENTAL
Intervention: Placental malaria
Number of subjects: 473

Group type: COMPARATOR
Intervention: Peripheral infection without placental sequestration
Number of subjects: 473

Group type: COMPARATOR
Intervention: No malaria during pregnancy
Number of subjects: 473
Study: 25503414

Group type: EXPERIMENTAL
Intervention: Formal education protocol including verbal and written instructions and verbal repetition of instructions (Clinic 1)
Number of subjects: 330

Group type: COMPARATOR
Intervention: No specific education policy (Clinic 2)
Number of subjects: 330
Study: 23456769

Group type: EXPERIMENTAL
Intervention: Folic acid 200 μg for 12 weeks
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Folic acid 400 μg for 12 weeks
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Folic acid 400 μg compared to 200 μg
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Folic acid 400 μg compared to 0 μg
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Folic acid 400 μg
Number of subjects: 142
Study: 20705350

Group type: EXPERIMENTAL
Intervention: Echocardiography measurement of epicardial adipose tissue (EAT) thickness
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein-cholesterol (LDL-C) measurement
Number of subjects: 120
Study: 19244569

Group type: EXPERIMENTAL
Intervention: Pramlintide
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 17105658

Group type: COMPARATOR
Intervention: CQ
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: CQ + SP
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Primaquine (45 mg single dose)
Number of subjects: 117
Study: 15585774

Group type: EXPERIMENTAL
Intervention: Isocaloric, nutrient-enriched preterm formula
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control preterm formula
Number of subjects: 37
Study: 11398582

Group type: EXPERIMENTAL
Intervention: Divina (2 mg valerate estradiol and 10 mg medroxyprogesterone acetate)
Number of subjects: 0
Study: 9267584

Group type: EXPERIMENTAL
Intervention: Trace elements/zinc 20 mg
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Selenium 100 micrograms
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Vitamins (vitamin C 120 mg; beta‐carotene 6 mg; alpha‐tocopherol 15 mg)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Combination of trace elements and vitamins at equal doses
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 8453855

Group type: EXPERIMENTAL
Intervention: Felodipine (10 mg every day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg twice a day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3087688

Group type: EXPERIMENTAL
Intervention: Sublingual administration of 1 mg nitroglycerin
Number of subjects: 7

Group type: COMPARATOR
Intervention: No intervention (tilting without collapse)
Number of subjects: 7
Study: 30794607

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 1054

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1054
Study: 29505804

Group type: EXPERIMENTAL
Intervention: Optimal antidepressant monotherapy (imipramine or venlafaxine) for 7 weeks
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Subsequent plasma level-targeted dose lithium addition for 4 weeks
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Subsequent electroconvulsive therapy
Number of subjects: 85
Study: 26555605

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 607

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 607
Study: 24462108

Group type: EXPERIMENTAL
Intervention: Lateral wedge insole
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 40
Study: 22431703

Group type: EXPERIMENTAL
Intervention: Systemic treatment plus RFA
Number of subjects: 119

Group type: COMPARATOR
Intervention: Systemic treatment alone
Number of subjects: 119
Study: 19640958

Group type: EXPERIMENTAL
Intervention: Vitamin A Supplementation (VAS)
Number of subjects: 11722
Study: 17548550

Group type: EXPERIMENTAL
Intervention: Tutoring with memory training
Number of subjects: 11

Group type: COMPARATOR
Intervention: Tutoring without memory training
Number of subjects: 11
Study: 15779091

Group type: EXPERIMENTAL
Intervention: Baseline data used for trial design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Analysis of 'change from baseline'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various trial design strategies
Number of subjects: 0
Study: 11912374

Group type: COMPARATOR
Intervention: Diclofenac alone
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Diclofenac combined with alfentanil patient controlled analgesia
Number of subjects: 64
Study: 9474633

Group type: EXPERIMENTAL
Intervention: Cold compression dressings
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wool and crepe dressings
Number of subjects: 40
Study: 7533517

Group type: EXPERIMENTAL
Intervention: FEMTX (fluorouracil, epidoxorubicin, methotrexate)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: FEMTX
Number of subjects: 41
Study: 1353540

Group type: EXPERIMENTAL
Intervention: Buserelin (20 micrograms, administered daily in a nasal spray)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotropin (administered after buserelin treatment)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 59
Study: 6426830

Group type: EXPERIMENTAL
Intervention: Naloxone (0.2 mg/kg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: LHRH (100 micrograms)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline (0.9%)
Number of subjects: 13
Study: 29951902

Group type: EXPERIMENTAL
Intervention: Health education intervention for breast cancer detection and screening
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 150
Study: 29274507

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet) rich in olive oil, 35% of calories from fat (22% monounsaturated) and 50% from carbohydrates, for 1.5 years
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet) rich in olive oil, for 1.5 years
Number of subjects: 805

Group type: COMPARATOR
Intervention: Low-fat diet (LF diet), for 1.5 years
Number of subjects: 805
Study: 26771873

Group type: EXPERIMENTAL
Intervention: Short course radiation (SC)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Long course chemoradiation (LC)
Number of subjects: 326
Study: 24687848

Group type: EXPERIMENTAL
Intervention: Behavioral Parent Training (BPT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Optimally dosed medication
Number of subjects: 12
Study: 23675990

Group type: EXPERIMENTAL
Intervention: Fermented red ginseng (FRG)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 20442989

Group type: EXPERIMENTAL
Intervention: Rapid decline group (RPD, n = 20)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Slow or absent decline group (SLW, n = 18)
Number of subjects: 38
Study: 18597078

Group type: EXPERIMENTAL
Intervention: Bifeprunox 20 mg
Number of subjects: 589

Group type: COMPARATOR
Intervention: Bifeprunox (5 mg, 10 mg)
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: Bifeprunox
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: Risperidone 6 mg
Number of subjects: 589

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 589
Study: 16021194

Group type: EXPERIMENTAL
Intervention: Peribulbar anaesthesia
Number of subjects: 220

Group type: COMPARATOR
Intervention: Oral diazepam, mefenamic acid, acetaminophen (alone or in combination)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Intramuscular injection of ketorolac tromethamine
Number of subjects: 220
Study: 14508365

Group type: EXPERIMENTAL
Intervention: Itraconazole (5.0 mg/kg orally, preoperatively, 2.5 mg/kg orally, two times a day, postoperatively)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 71
Study: 10961161

Group type: EXPERIMENTAL
Intervention: Acarbose (100 mg three times per day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 8672323

Group type: EXPERIMENTAL
Intervention: 10% low‐molecular weight (LMW) hydroxyethylstarch solution (HES) in sepsis patients
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 20% human albumin (HA) in sepsis patients
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10% low‐molecular weight (LMW) hydroxyethylstarch solution (HES) in trauma patients
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 20% human albumin (HA) in trauma patients
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HES in sepsis patients
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HA in sepsis patients
Number of subjects: 60
Study: 2666205

Group type: EXPERIMENTAL
Intervention: benztropine (mean dose 3.8 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 14602

Group type: EXPERIMENTAL
Intervention: Propoxyphene napsylate at maximum doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propoxyphene napsylate at maximum subtoxic levels
Number of subjects: 0
Study: 31033154

Group type: EXPERIMENTAL
Intervention: Bioresorbable polymer sirolimus-eluting stent (BP-SES; Ultimaster)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Permanent polymer everolimus-eluting stent (PP-EES; Xience)
Number of subjects: 456
Study: 30030779

Group type: EXPERIMENTAL
Intervention: Perception condition (participants saw the color scale and an eye picture simultaneously)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Memory condition (participants matched the color of an eye to the color scale from memory)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Label condition (participants labeled the eye orally before matching the color from memory)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 0
Study: 27892728

Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel, cisplatin, cetuximab, and radiation
Number of subjects: 34
Study: 26460660

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (250 mg at anaesthetic induction and 250 mg at initiation of cardiopulmonary bypass)
Number of subjects: 7507

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7507

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 7507
Study: 24004517

Group type: EXPERIMENTAL
Intervention: mHealth intervention group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard care control group
Number of subjects: 20
Study: 21551479

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control
Number of subjects: 150
Study: 18296556

Group type: EXPERIMENTAL
Intervention: Montelukast 4 mg oral granules
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Montelukast 8 mg once daily for 7 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Montelukast 4 mg once daily for 7 days
Number of subjects: 12
Study: 16575620

Group type: COMPARATOR
Intervention: Conventional operation with monopolar electrocautery and handsewn anastomosis (Group 1)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel and circular stapler (Group 2)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study: 14739625

Group type: EXPERIMENTAL
Intervention: Aspirin alone
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Aspirin combined with heparin
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Aspirin combined with heparin and ultrasound
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Eptifibatide combined with aspirin, heparin, and ultrasound
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Tirofiban combined with aspirin, heparin, and ultrasound
Number of subjects: 320
Study: 10958091

Group type: EXPERIMENTAL
Intervention: 3 microg x kg(‐1) oral clonidine
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 8769388

Group type: COMPARATOR
Intervention: Octreotide 100 micrograms subcutaneously three times daily for 3 to 6 weeks before surgery (group 1)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Octreotide 100 micrograms subcutaneously three times daily for 3 to 9 months (group 2)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Octreotide 500 micrograms subcutaneously three times daily (increased dose for incomplete suppression in group 2)
Number of subjects: 172
Study: 8446671

Group type: EXPERIMENTAL
Intervention: Caffeine citrate 1 mg/kg body weight
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Caffeine citrate 2 mg/kg body weight
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Caffeine citrate 3 mg/kg body weight
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Caffeine citrate 4 mg/kg body weight
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Caffeine (any dose)
Number of subjects: 300
Study: 2946644

Group type: EXPERIMENTAL
Intervention: Procaterol (20 mcg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Salbutamol (200 mcg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29261442

Group type: EXPERIMENTAL
Intervention: ADT plus docetaxel
Number of subjects: 719

Group type: COMPARATOR
Intervention: ADT alone
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 719
Study: 27585671

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 602

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 602
Study: 25218600

Group type: EXPERIMENTAL
Intervention: Memantine (20 mg/d after 1 month of titration)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 22778120

Group type: EXPERIMENTAL
Intervention: Practice-based training program for screening, diagnosis, and management of postpartum depression
Number of subjects: 2343

Group type: COMPARATOR
Intervention: Usual care (30-minute presentation about postpartum depression)
Number of subjects: 2343
Study: 19888921

Group type: EXPERIMENTAL
Intervention: Melatonin 5 mg (2.5 mg for <6 years)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 18716362

Group type: EXPERIMENTAL
Intervention: Azelnidipine (AZ) 16 mg/d
Number of subjects: 38

Group type: COMPARATOR
Intervention: Nifedipine-CR (NF) 40 mg/d
Number of subjects: 38
Study: 15729174

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) added to regimen after withdrawal of cyclosporine A (CsA)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Cyclosporine A (CsA) continued
Number of subjects: 122
Study: 12775230

Group type: EXPERIMENTAL
Intervention: TACE (transcatheter arterial chemoembolization)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Non-TACE group (control)
Number of subjects: 136
Study: 10321327

Group type: EXPERIMENTAL
Intervention: Chronic alcoholics with polyneuropathy
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Chronic alcoholics with spasticity
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Chronic alcoholics with polyneuropathy without spasticity
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthy volunteers (controls)
Number of subjects: 34
Study: 9173440

Group type: EXPERIMENTAL
Intervention: CA 15-3 levels in breast cancer patients
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: CA 15-3 test
Number of subjects: 430
Study: 1836066

Group type: EXPERIMENTAL
Intervention: Calcium antagonist isradipine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 6580439

Group type: EXPERIMENTAL
Intervention: Occlusal splints at 4.42 mm (Group II)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Occlusal splints at 8.15 mm (Group III)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Occlusal splints at 1 mm (Group I)
Number of subjects: 75
Study: 30230375

Group type: EXPERIMENTAL
Intervention: Flash-free adhesive (APC Flash‐Free Adhesive, 3M Unitek)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional adhesive (APCII Adhesive, 3M Unitek)
Number of subjects: 45
Study: 28668229

Group type: EXPERIMENTAL
Intervention: Daily oral dose of probiotics for three weeks or until they gave birth
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 34
Study: 27118297

Group type: EXPERIMENTAL
Intervention: Manual hyperinflation delivered by nurses
Number of subjects: 33
Study: 23180751

Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Foam sclerotherapy
Number of subjects: 100
Study: 22040616

Group type: EXPERIMENTAL
Intervention: Faxed referral program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (quit advice and printed information)
Number of subjects: 0
Study: 19436282

Group type: EXPERIMENTAL
Intervention: AST-120 (spherical carbon adsorbent) 2-g sachets, oral, thrice a day for 4 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: AST-120 (spherical carbon adsorbent)
Number of subjects: 20
Study: 17370490

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Hegu (LI 4) and Sanyinjiao (SP 6) simultaneously
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Hegu (LI 4) and Sanyinjiao (SP 6) successively
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group treated with medicine
Number of subjects: 90
Study: 15505150

Group type: EXPERIMENTAL
Intervention: AVP-923 (30 mg of DM plus 30 mg of Q) given twice daily for 28 days
Number of subjects: 140

Group type: COMPARATOR
Intervention: DM (dextromethorphan hydrobromide)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Q (quinidine sulfate)
Number of subjects: 140
Study: 11218745

Group type: EXPERIMENTAL
Intervention: Super-high-flow injection method (Group A)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional injection method (Group B)
Number of subjects: 200
Study: 9684799

Group type: EXPERIMENTAL
Intervention: TFPI
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Protein C
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Inflammation-sensitive proteins, lipids, and coagulation factors
Number of subjects: 400